サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316750

心臓バイオマーカー診断キット市場：疾患別、検査別、製品別、エンドユーザー別-2023-2030年の世界予測

Cardiac Biomarker Diagnostic Kits Market by Disease, Testing, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心臓バイオマーカー診断キット市場：疾患別、検査別、製品別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓バイオマーカー診断キットの世界市場は、2023年に37億8,465万米ドル、CAGR 8.91%で大きく成長し、2030年には68億8,842万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の心臓バイオマーカー診断キット市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.心臓バイオマーカー診断キットの世界市場規模および予測は？

2.予測期間中、世界の心臓バイオマーカー診断キット市場を形成するCOVID-19の阻害要因と影響は？

3.心臓バイオマーカー診断キットの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.心臓バイオマーカー診断キットの世界市場における競争戦略は？

5.心臓バイオマーカー診断キットの世界市場における技術動向と規制の枠組みは？

6.心臓バイオマーカー診断キットの世界市場における主要ベンダーの市場シェアは？

7.心臓バイオマーカー診断キットの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で心血管疾患の症例が増加
      • 高齢者人口の増加とそれに伴う慢性疾患の負担の増加
      • 早期診断と治療に対する消費者の嗜好の高まり
    • 抑制要因
      • サンプルの収集と保管に関する懸念
    • 機会
      • 新たな開発に向けた研究開発努力の増加
      • ポイントオブケア検査（POCT）の増加傾向
    • 課題
      • 支援的な償還ポリシーの欠如
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 心臓バイオマーカー診断キット市場：疾患別

  • 狭心症
  • 心不全
  • 心筋梗塞

第7章 心臓バイオマーカー診断キット市場テスト別

  • 臨床検査
  • ポイントオブケア検査

第8章 心臓バイオマーカー診断キット市場：製品別

  • BNPテストキット
  • C反応性タンパク質
  • CK-MB検査キット
  • ミオグロビン検査キット
  • トロポニン検査キット

第9章 心臓バイオマーカー診断キット市場：エンドユーザー別

  • クリニック
  • 診断センター
  • 病院

第10章 南北アメリカの心臓バイオマーカー診断キット市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の心臓バイオマーカー診断キット市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの心臓バイオマーカー診断キット市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
  • FIGURE 5. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2022 VS 2030 (%)
  • FIGURE 6. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 7. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET DYNAMICS
  • FIGURE 10. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 5. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFRACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 9. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BNP TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CK-MB TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TROPONIN TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET LICENSE & PRICING
目次
Product Code: MRR-433AB1DC288B

The Global Cardiac Biomarker Diagnostic Kits Market is forecasted to grow significantly, with a projected USD 3,784.65 million in 2023 at a CAGR of 8.91% and expected to reach a staggering USD 6,888.42 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cardiac Biomarker Diagnostic Kits Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cardiac Biomarker Diagnostic Kits Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease, market is studied across Angina Pectoris, Cardiac Heart Failure, and Myocardial Infraction. The Cardiac Heart Failure is projected to witness significant market share during forecast period.

Based on Testing, market is studied across Laboratory Testing and Point of Care Testing. The Laboratory Testing is projected to witness significant market share during forecast period.

Based on Product, market is studied across BNP Test Kit, C-Reactive Protein, CK-MB Test Kits, Myoglobin Test Kits, and Troponin Test Kits. The Troponin Test Kits is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Clinics, Diagnostics Centers, and Hospitals. The Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cardiac Biomarker Diagnostic Kits Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cardiac Biomarker Diagnostic Kits Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Biomarker Diagnostic Kits Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Biomarker Diagnostic Kits Market?

4. What is the competitive strategic window for opportunities in the Global Cardiac Biomarker Diagnostic Kits Market?

5. What are the technology trends and regulatory frameworks in the Global Cardiac Biomarker Diagnostic Kits Market?

6. What is the market share of the leading vendors in the Global Cardiac Biomarker Diagnostic Kits Market?

7. What modes and strategic moves are considered suitable for entering the Global Cardiac Biomarker Diagnostic Kits Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cardiac Biomarker Diagnostic Kits Market, by Disease, 2022 vs 2030
  • 4.3. Cardiac Biomarker Diagnostic Kits Market, by Testing, 2022 vs 2030
  • 4.4. Cardiac Biomarker Diagnostic Kits Market, by Product, 2022 vs 2030
  • 4.5. Cardiac Biomarker Diagnostic Kits Market, by End-User, 2022 vs 2030
  • 4.6. Cardiac Biomarker Diagnostic Kits Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cardiovascular diseases worldwide
      • 5.1.1.2. Rising geriatric population and the consequent increase in the burden of chronic diseases
      • 5.1.1.3. Growing consumer preference for early diagnosis and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to sample collection and storage
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in R&D efforts for new developments
      • 5.1.3.2. Growing trend of Point-of-care testing (POCT)
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of supportive reimbursement policies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cardiac Biomarker Diagnostic Kits Market, by Disease

  • 6.1. Introduction
  • 6.2. Angina Pectoris
  • 6.3. Cardiac Heart Failure
  • 6.4. Myocardial Infraction

7. Cardiac Biomarker Diagnostic Kits Market, by Testing

  • 7.1. Introduction
  • 7.2. Laboratory Testing
  • 7.3. Point of Care Testing

8. Cardiac Biomarker Diagnostic Kits Market, by Product

  • 8.1. Introduction
  • 8.2. BNP Test Kit
  • 8.3. C-Reactive Protein
  • 8.4. CK-MB Test Kits
  • 8.5. Myoglobin Test Kits
  • 8.6. Troponin Test Kits

9. Cardiac Biomarker Diagnostic Kits Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostics Centers
  • 9.4. Hospitals

10. Americas Cardiac Biomarker Diagnostic Kits Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Biomarker Diagnostic Kits Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Biomarker Diagnostic Kits Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing